CASI PHARMACEUTICALS, INC. Investments, Fair Value Disclosure
CASI PHARMACEUTICALS, INC. (CASIF) had Investments, Fair Value Disclosure of $2.62 million as of 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes
us-gaap:InvestmentsFairValueDisclosure · last filed 2026-05-15
- 2024-12-31: Investments, Fair Value Disclosure $2.62M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2024-12-31 | $2.62M 20-F · filed 2026-05-15 |